JAMP Methotrexate 10 mg Tablets: Affected lots may contain oversized tablets.
Brand(s)
Last updated
Summary
Product
JAMP Methotrexate 10 mg Tablets
Issue
Health products - Product quality
What to do
Consult your healthcare provider prior to discontinuing use of the affected product, or if you have any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot Number |
|---|---|---|---|---|---|
| JAMP Pharma | JAMP Methotrexate Tablets | DIN 02553740 | Tablet | 10 mg | 25JME01, 25JME02 |
Issue
Affected lots may contain oversized tablets.
What you should do
- Verify whether your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product, or if you have any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
JAMP Pharma Corporation
1310 rue Nobel
Boucherville Québec, J4B 5H3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Recall date
Identification number
RA-82429
Get notified
Receive emails about new and updated recall and safety alerts.